Our approach to intellectual property (IP) derives from our broader purpose to reimagine medicine to improve and extend people’s lives. We use patents and other IP rights as a means to enable the discovery and development of breakthrough medical innovations, to facilitate their delivery to the patients who need them, and to promote scientific and technological progress for patients and society. The following are some of the industry-leading practices and initiatives that comprise our patient-centered approach to IP.
Our approach to patents in the world’s poorest countries
全国十大赌博官网制药 recognizes the unique socio-economic challenges faced by the world’s poorest countries, 包括 challenges that may interfere with the proper functioning of market-based incentives like intellectual property rights. 相应的, 全国十大赌博官网制药 does not seek or enforce patents in least developed countries (LDCs, (由联合国指定), 低收入国家, (由世界银行指定), or in around 80% of the lower-middle income countries (LMICs, (由世界银行指定). In the small number of LMICs where we do seek or enforce patents, we aim to limit them to those patent applications covering new molecular entities. 除了, we are committed to granting non-exclusive licenses to qualified third parties for supply of our patented products exclusively to LDCs or to LICs
促进专利信息的获取
In 2018, the World Intellectual Property Organization (WIPO) and the international Federation of Pharmaceutical Manufacturers & 协会推出 Patent Information Initiative for Medicines (Pat-INFORMED).
Pat-INFORMED, 全国十大赌博官网是创始成员之一, is a unique public online resource launched to provide basic patent information for medicines of participating companies, and to help members of the global health community that are involved in procurement decisions obtain relevant information about a medicine’s patent status. 全国十大赌博官网制药 was the first company to have listed patent information for all of our small-molecule medicines in the Pat-INFORMED database, which goes significantly beyond the program’s near-term goal of capturing information for medicines in a more limited set of disease areas. 除了, we continue to drive the industry effort to include patent information for additional medicines.
Sharing our values and our patient-centric approach to IP
全国十大赌博官网制药 is also a founding member and signatory of the IP Principles for Advancing Cures and Therapies (IP协议). 于2021年4月发射 IP协议 is a public statement of our patient-centric approach to IP that explains some of the ways that we and other signatory companies use, 并承诺使用, the IP system for the benefit of patients and society. Consistent with our longstanding company approach to IP described above, 这10项原则涵盖了关键主题, 包括
- 全国十大赌博官网如何以患者为中心申请和执行知识产权;
- how we use IP to advance innovation, collaboration, scientific progress, and public health;
- the importance of generics and biosimilars; and
- 全国十大赌博官网如何在世界上最贫穷的国家处理知识产权问题.
扩大对专利制度的利用
Further, we continue our pro bono efforts in the IP space through the 发明人援助计划, a WIPO initiative in collaboration with the World Economic Forum. 这个项目, 全国十大赌博官网是创始成员之一, matches inventors and small businesses of limited financial means in developing countries with qualified patent attorneys, 谁提供无偿法律援助. 自2015年该项目启动以来, we have supported its implementation in each of its seven participating countries—Chile, 哥伦比亚, 厄瓜多尔, 摩洛哥, 秘鲁, 菲律宾, and South 非洲—and aim to help expand it to additional developing countries.